Show simple item record

dc.contributor.authorDe-Colle, C
dc.contributor.authorKirby, A
dc.contributor.authorRussell, N
dc.contributor.authorShaitelman, SF
dc.contributor.authorCurrey, A
dc.contributor.authorDonovan, E
dc.contributor.authorHahn, E
dc.contributor.authorHan, K
dc.contributor.authorAnandadas, CN
dc.contributor.authorMahmood, F
dc.contributor.authorLorenzen, EL
dc.contributor.authorvan den Bongard, D
dc.contributor.authorGroot Koerkamp, ML
dc.contributor.authorHouweling, AC
dc.contributor.authorNachbar, M
dc.contributor.authorThorwarth, D
dc.contributor.authorZips, D
dc.coverage.spatialIreland
dc.date.accessioned2023-03-09T12:50:29Z
dc.date.available2023-03-09T12:50:29Z
dc.date.issued2023-03-01
dc.identifier100564
dc.identifierS2405-6308(22)00122-7
dc.identifier.citationClinical and Translational Radiation Oncology, 2023, 39 pp. 100564 -en_US
dc.identifier.issn2405-6308
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/5715
dc.identifier.eissn2405-6308
dc.identifier.eissn2405-6308
dc.identifier.doi10.1016/j.ctro.2022.100564
dc.description.abstractResearch in the field of local and locoregional breast cancer radiotherapy aims to maintain excellent oncological outcomes while reducing treatment-related toxicity. Adaptive radiotherapy (ART) considers variations in target and organs at risk (OARs) anatomy occurring during the treatment course and integrates these in re-optimized treatment plans. Exploiting ART routinely in clinic may result in smaller target volumes and better OAR sparing, which may lead to reduction of acute as well as late toxicities. In this review MR-guided and CT-guided ART for breast cancer patients according to different clinical scenarios (neoadjuvant and adjuvant partial breast irradiation, whole breast, chest wall and regional nodal irradiation) are reviewed and their advantages as well as challenging aspects discussed.
dc.formatElectronic-eCollection
dc.format.extent100564 -
dc.languageeng
dc.language.isoengen_US
dc.publisherElsevier BVen_US
dc.relation.ispartofClinical and Translational Radiation Oncology
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.subjectAdaptive radiotherapy
dc.subjectBreast cancer
dc.subjectMR-linac
dc.subjectPartial breast irradiation
dc.titleAdaptive radiotherapy for breast cancer.en_US
dc.typeJournal Article
dcterms.dateAccepted2022-12-14
dc.date.updated2023-03-09T12:48:33Z
rioxxterms.versionVoRen_US
rioxxterms.versionofrecord10.1016/j.ctro.2022.100564en_US
rioxxterms.licenseref.startdate2023-03-01
rioxxterms.typeJournal Article/Reviewen_US
pubs.author-urlhttps://www.ncbi.nlm.nih.gov/pubmed/36632056
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Breast Cancer Radiotherapy
pubs.organisational-group/ICR/Primary Group/Royal Marsden Clinical Units
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Breast Cancer Radiotherapy/Breast Cancer Radiotherapy (hon.)
pubs.publication-statusPublished online
pubs.publisher-urlhttp://dx.doi.org/10.1016/j.ctro.2022.100564
pubs.volume39
dc.contributor.icrauthorKirby, Anna
icr.provenanceDeposited by Mr Arek Surman on 2023-03-09. Deposit type is initial. No. of files: 1. Files: Adaptive radiotherapy for breast cancer.pdf


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by-nc-nd/4.0/
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by-nc-nd/4.0/